Close Menu

stock offering

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Exact Sciences today said that it has raised net proceeds of $27.1 million in a public offering of common stock.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Pressure BioSciences on Monday filed a preliminary registration form with the US Securities and Exchange Commission to raise up to $8 million.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Response Biomedical this week said it has filed the final prospectus for its offering to raise C$8 million (US$7.9 million).

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Sequenom has filed a Form S-3 with the US Securities and Exchange Commission covering the potential sale of securities worth $150 million.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has entered into definitive agreements with certain investors for a registered direct offering of 843 units priced at $1,000 per unit.

The company will use funds from the offering to market its products, invest in a Singapore plasma project, and for general corporate purposes.

The company will receive no proceeds from the offering but could receive $34.8 million if warrants included in the offering are exercised in full.

Some of the proceeds will be used to fund development of the firm's NexGen molecular diagnostics system.

The offering is expected to bring in net proceeds of at least $877.4 million.

Net proceeds will be used to pay a part of its acquisition of Beckman Coulter, which is expected to close by the end of the month.

Pages

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.

LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.

In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.